ZA9710919B - Pharmaceutical compositions containing N-sulphony-lindole derivatives - Google Patents

Pharmaceutical compositions containing N-sulphony-lindole derivatives

Info

Publication number
ZA9710919B
ZA9710919B ZA9710919A ZA9710919A ZA9710919B ZA 9710919 B ZA9710919 B ZA 9710919B ZA 9710919 A ZA9710919 A ZA 9710919A ZA 9710919 A ZA9710919 A ZA 9710919A ZA 9710919 B ZA9710919 B ZA 9710919B
Authority
ZA
South Africa
Prior art keywords
lindole
sulphony
derivatives
pharmaceutical compositions
compositions containing
Prior art date
Application number
ZA9710919A
Other languages
English (en)
Inventor
Jean-Claude Gautier
Simon John Fuller
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of ZA9710919B publication Critical patent/ZA9710919B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
ZA9710919A 1996-12-05 1997-12-04 Pharmaceutical compositions containing N-sulphony-lindole derivatives ZA9710919B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9614957A FR2756736B1 (fr) 1996-12-05 1996-12-05 Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline

Publications (1)

Publication Number Publication Date
ZA9710919B true ZA9710919B (en) 1999-06-04

Family

ID=9498376

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9710919A ZA9710919B (en) 1996-12-05 1997-12-04 Pharmaceutical compositions containing N-sulphony-lindole derivatives

Country Status (25)

Country Link
EP (1) EP0941090A1 (fr)
JP (1) JP2000507618A (fr)
KR (1) KR20000069308A (fr)
CN (1) CN1239887A (fr)
AR (1) AR009651A1 (fr)
AU (1) AU716575B2 (fr)
BR (1) BR9712406A (fr)
CA (1) CA2273990A1 (fr)
CO (1) CO4910129A1 (fr)
DZ (1) DZ2362A1 (fr)
EE (1) EE9900206A (fr)
FR (1) FR2756736B1 (fr)
HU (1) HUP0001386A3 (fr)
ID (1) ID23373A (fr)
IL (1) IL129936A0 (fr)
IS (1) IS5062A (fr)
MY (1) MY132819A (fr)
NO (1) NO992724L (fr)
NZ (1) NZ335750A (fr)
RU (1) RU2174394C2 (fr)
SK (1) SK75599A3 (fr)
TR (1) TR199901702T2 (fr)
WO (1) WO1998024430A1 (fr)
YU (1) YU23099A (fr)
ZA (1) ZA9710919B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786486B3 (fr) * 1998-11-16 2000-12-08 Sanofi Sa Procede de preparation du (2s)-1-[(2r,3s)-5-chloro-3-(2- chlorophenyl)-1-(3,4-dimethoxy benzenesulfonyl)-3-hydroxy- 2,3-dihydro-1h-indole-2-carbonyl]pyrrolidine-2-carboxamide, de ses solvats et/ou hydrates
DE19913692A1 (de) * 1999-03-25 2000-09-28 Basf Ag Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
WO2001034119A2 (fr) 1999-11-12 2001-05-17 Abbott Laboratories Inhibiteurs de cristallisation dans une dispersion solide
FR2805992A1 (fr) * 2000-03-08 2001-09-14 Sanofi Synthelabo Compositions pharmaceutiques orales contenant des derives de n-sulfonylindoline
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
ITMI20011338A1 (it) * 2001-06-26 2002-12-26 Farmatron Ltd Composizioni farmaceutiche orali a rilascio immediato del principio attivo
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
UA119324C2 (uk) * 2013-04-02 2019-06-10 Теміс Медікер Лімітед Композиції фармацевтично активних речовин, що містять моноетиловий ефір діетиленгліколю або інші алкільні похідні
KR102139339B1 (ko) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물
KR102139338B1 (ko) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
FR2679903B1 (fr) * 1991-08-02 1993-12-03 Elf Sanofi Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
WO1998024430A1 (fr) 1998-06-11
ID23373A (id) 2000-04-20
FR2756736A1 (fr) 1998-06-12
NO992724D0 (no) 1999-06-04
RU2174394C2 (ru) 2001-10-10
TR199901702T2 (en) 1999-09-21
CA2273990A1 (fr) 1998-06-11
EP0941090A1 (fr) 1999-09-15
BR9712406A (pt) 1999-08-31
CN1239887A (zh) 1999-12-29
AR009651A1 (es) 2000-04-26
DZ2362A1 (fr) 2002-12-28
CO4910129A1 (es) 2000-04-24
SK75599A3 (en) 2000-08-14
IL129936A0 (en) 2000-02-29
AU5326298A (en) 1998-06-29
MY132819A (en) 2007-10-31
EE9900206A (et) 1999-12-15
NO992724L (no) 1999-06-04
NZ335750A (en) 2001-06-29
AU716575B2 (en) 2000-03-02
HUP0001386A2 (hu) 2001-04-28
JP2000507618A (ja) 2000-06-20
FR2756736B1 (fr) 1999-03-05
YU23099A (en) 1999-11-22
KR20000069308A (ko) 2000-11-25
IS5062A (is) 1999-06-01
HUP0001386A3 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
HUP9902455A3 (en) 6-phenylpyridyl-2-amine derivatives, pharmaceutical compositions containing them
EG24118A (en) Pharmaceutical compositions
NZ304982A (en) Pyridinyloxy- or pyridinylamino-acetamide derivatives; pharmaceutical compositions
IL181059A0 (en) Pharmaceutical compositions containing isoflavones
HUP9900424A2 (hu) Tiazolil-benzfurán-származékok és a vegyületeket tartalmazó gyógyászati készítmények
HUP9901452A3 (en) Bicyclic-aromatic compounds and pharmaceutical compositions containing them
GB9616672D0 (en) Pharmaceutical compositions
ZA9710006B (en) Novel pharmaceutical compositions
EP0755250A4 (fr) Compositions pharmaceutiques contenant du benzamide
GB9610359D0 (en) Pharmaceutical compositions
AU5326298A (en) Pharmaceutical compositions containing N-sulphonylindoline derivatives
GB9622681D0 (en) Pharmaceutical compositions
GB9606429D0 (en) Pharmaceutical compositions
ZA959081B (en) Pharmaceutical compositions
GB9613457D0 (en) Pharmaceutical compositions
GB9623962D0 (en) Pharmaceutical composition
GB9610136D0 (en) Pharmaceutical compositions
GB9618376D0 (en) Pharmaceutical compositions
HUP0000275A3 (en) Phenanethridinium derivatives and pharmaceutical compositions containing them
GB2295825B (en) Pharmaceutical compositions
HUP9903539A3 (en) Substituted amidinobenzene derivatives and pharmaceutical compositions containing them
HUP9901968A3 (en) 2-thioxotetrahydropyrimidin-4-one derivatives and pharmaceutical compositions containing them
IL132784A0 (en) Pharmaceutical compositions containing dronabinol
GB9400047D0 (en) Pharmaceutical compositions
HUP0003528A3 (en) Pharmaceutical compositions containing dihydropolyprenols